We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-2.48%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$812B
AUM Growth
-$55.8B
Cap. Flow
-$18.8B
Cap. Flow %
-2.31%
Top 10 Hldgs %
32.22%
Holding
3,109
New
91
Increased
2,002
Reduced
738
Closed
70

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$3.81B
2
XYZ
Block Inc
XYZ
+$1.46B
3
ACN icon
Accenture
ACN
+$1.23B
4
GILD icon
Gilead Sciences
GILD
+$1.15B
5
VLO icon
Valero Energy
VLO
+$1.05B

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$4.61B
2
META icon
Meta Platforms (Facebook)
META
+$2.06B
3
TSLA icon
Tesla
TSLA
+$1.81B
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$1.72B
5
AMZN icon
Amazon
AMZN
+$1.59B

Sector Composition

Rank Sector Weight
1 Technology 30.44%
2 Healthcare 13.92%
3 Financials 12.3%
4 Consumer Discretionary 10.98%
5 Communication Services 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GUTS icon
3001
Fractyl Health
GUTS
$111M
$14K ﹤0.01%
11,313
LNZA icon
3002
LanzaTech
LNZA
$67.1M
$13K ﹤0.01%
523
DRRX
3003
DELISTED
DURECT Corp
DRRX
$12K ﹤0.01%
14,210
LIDR icon
3004
AEye
LIDR
$61.4M
$12K ﹤0.01%
20,196
STTK icon
3005
Shattuck Labs
STTK
$752M
$12K ﹤0.01%
12,603
HBIO icon
3006
Harvard Bioscience
HBIO
$28.1M
$8K ﹤0.01%
1,262
IPSC icon
3007
Century Therapeutics
IPSC
$355M
$8K ﹤0.01%
14,882
MKTW icon
3008
MarketWise
MKTW
$55.5M
$8K ﹤0.01%
802
SCWO icon
3009
374Water
SCWO
$41.1M
$8K ﹤0.01%
2,263
ALXO icon
3010
ALX Oncology
ALXO
$278M
$7K ﹤0.01%
10,622
PRPH
3011
DELISTED
ProPhase Labs
PRPH
$7K ﹤0.01%
1,730
SST icon
3012
System1
SST
$19.8M
$7K ﹤0.01%
1,760
OVID icon
3013
Ovid Therapeutics
OVID
$489M
$6K ﹤0.01%
17,396
ELEV
3014
DELISTED
Elevation Oncology
ELEV
$5K ﹤0.01%
16,841
STI icon
3015
Solidion Technology
STI
$65.6M
$4K ﹤0.01%
632
LYRA
3016
DELISTED
LYRA THERAPEUTICS INC
LYRA
$3K ﹤0.01%
351
GCTS.WS
3017
GCT Semiconductor Holding Warrants
GCTS.WS
$18.4M
$3K ﹤0.01%
37,675
SBDS
3018
DELISTED
Solo Brands Inc
SBDS
$3K ﹤0.01%
333
SRZNW
3019
DELISTED
Surrozen Inc Warrant
SRZNW
$2K ﹤0.01%
41,666
VSTEW
3020
DELISTED
Vast Renewables Limited Warrants
VSTEW
$2K ﹤0.01%
38,375
ABEV icon
3021
Ambev
ABEV
$43.5B
-3,297,220
Closed -$6.1M
ACI icon
3022
CALL
Albertsons Companies
ACI
$5.83B
-30,700
Closed -$602K
ANGI icon
3023
Angi Inc
ANGI
$176M
-1,410
Closed -$24K
BEP icon
3024
Brookfield Renewable
BEP
$10.3B
-50,653
Closed -$1.16M
BILI icon
3025
Bilibili
BILI
$7.37B
-999,670
Closed -$18.1M

Similar funds

T. Rowe Price Associates's Q1 2025 Portfolio in Review

As of Q1 2025, T. Rowe Price Associates held 3,109 positions worth $812B, down 6.4% from $867B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

T. Rowe Price Associates's Q1 2025 filing shows 91 new, 2,002 increased, 738 reduced and 70 closed positions. Its largest new stake was T. Rowe Price Value ETF: 8,943,567 shares worth $283M. The largest sale was NVIDIA, an estimated $4.61B.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Healthcare and Financials.

  • T. Rowe Price Associates's largest Q1 2025 buy was T. Rowe Price Value ETF: 8,943,567 shares worth $283M.
  • T. Rowe Price Associates added most to Broadcom in Q1 2025, an estimated $3.81B increase.
  • T. Rowe Price Associates's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $4.61B.
  • T. Rowe Price Associates fully exited Summit Materials, Inc. Class A Common Stock in Q1 2025, selling an estimated $271M.
  • T. Rowe Price Associates's ten largest holdings make up 32% of its $812B portfolio in Q1 2025.
  • T. Rowe Price Associates opened 91 new positions and closed 70 in Q1 2025.
  • T. Rowe Price Associates's portfolio value fell 6.4% quarter-over-quarter to $812B.

Based on T. Rowe Price Associates's 13F filing for Q1 2025, filed 14 May 2025.